MENS NASDAQ
Jyong Biotech Ltd. Ordinary Shares
1W: +7.4%
1M: -3.1%
3M: -0.9%
YTD: -36.1%
1Y: -95.5%
$2.18
+0.15 (+7.39%)
Weekly Expected Move ±12.4%
$2
$2
$2
$2
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
-39.3% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$4M
-39.3% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
-208.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | -$4M | -$7M | -$4M | -$3M |
| Depreciation & Amort. | $110K | $122K | $123K | $127K | $120K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $25K | $1M | $3M | $1M | -$1M |
| Other Non-Cash Items | $694K | $849K | $599K | $554K | $761K |
| Operating Cash Flow | -$1M | -$2M | -$3M | -$3M | -$4M |
| — Investing Activities — | |||||
| Capital Expenditures | -$88K | -$137K | -$246K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | -$2M | -$292K | $0 | $0 |
| Investment Sales | $0 | $664K | $2M | $95K | $0 |
| Other Investing | $819K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $731K | -$1M | $1M | $95K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $2M | -$1M | $4M | $2M | $2M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $3M | -$35K | -$276K | -$445K | -$213K |
| Financing Cash Flow | $5M | -$1M | $3M | $2M | $2M |
| Net Change in Cash | $5M | -$5M | $2M | -$532K | -$2M |
| Cash End of Period | $5M | $551K | $2M | $2M | $101K |
| Free Cash Flow | -$1M | -$2M | -$3M | -$3M | -$4M |